Article
Tamarixetin Attenuated the Virulence of Staphylococcus aureus by Directly Targeting Caseinolytic Protease P
14 Jul 2022
Abstract excerpt
Staphylococcus aureus, especially drug-resistant S. aureus infections, is a worldwide healthcare challenge. There is a growing focus on antivirulence therapy against S. aureus . Caseinolytic protease p (ClpP) is a protein hydrolase essential for pathogenicity in S. aureus . A flavonoid compound, tamarixetin, which was screened in this work, was specifically able to inhibit the hydrolytic activity of ClpP on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
